Skip to main content

Table 4 Mean changes in body weight

From: Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model

Treatment

Body weight (gm)

Mean changes in body weight (gm)

0th day

29th day

 

HC

220 ± 6.56

250 ± 20.7

30.7 ± 3.93

NC

233 ± 9.36

252 ± 27.6

19.8 ± 3.6

Diclo

217 ± 7.05

244 ± 13.9

26.7 ± 2.74

Dasha

211 ± 5.81

240 ± 16

29.2 ± 2.27

DF1911-LD

223 ± 9.16

254 ± 27.6

31 ± 3.84

DF1911-MD

208 ± 3.13

234 ± 17.6

26.7 ± 4.57

DF1911-HD

223 ± 5.21

251 ± 12.8

28.3 ± 1.94

DF2112-LD

210 ± 5.62

238 ± 17.7

27.8 ± 5.63

DF2112-MD

213 ± 4.31

242 ± 8.02

28.5 ± 4.3

DF2112-HD

218 ± 5.78

249 ± 16.5

30.5 ± 2.57

DF2813-LD

220 ± 8.43

250 ± 23.8

30 ± 4.76

DF2813-MD

220 ± 11

250 ± 28.7

29.5 ± 4.9

DF2813-HD

214 ± 7.51

246 ± 17.8

32 ± 1.97

  1. HC healthy control, NC negative control, Diclo diclofenac sodium, Dasha Dashamoola Kwatha, DF Dashamoola formulation, LD lower dose, MD middle dose, HD higher dose. Values are expressed as Mean ± SEM; n = 6. Data were analysed by One-Way ANOVA followed by Dunnett’s multiple comparison test